| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | Germany | 3 | |
| #4 | Australia | 2 | |
| #5 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Peptides | |
| #3 | Heterocyclic compounds | |
| #4 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Steinmetzer Torsten | 14 |
| #2 | Schweinitz Andrea | 13 |
| #3 | Stuerzebecher Joerg | 11 |
| #4 | Stuerzebecher Anne | 8 |
| #5 | Uhland Kerstin | 4 |
| #6 | Doennecke Daniel | 4 |
| #7 | Sturzebecher Jorg | 3 |
| #8 | Sturzebecher Anne | 2 |
| #9 | Donnecke Daniel | 1 |
| #10 | Shweinitz Andrea | 1 |
| Publication | Filing date | Title |
|---|---|---|
| DE102005044319A1 | 2- (Aminomethyl) -5-chloro-benzylamide derivatives and their use as inhibitors of coagulation factor Xa | |
| DE10342108A1 | Basic substituted benzylamine analogs as coagulation factor Xa inhibitors, their preparation and use | |
| DE10301300A1 | Use of acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein |